The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00577967
Verified July 2010 by Hospital Authority, Hong Kong. Recruitment status was: Not yet recruiting
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Adult Chinese male and female patients aged > 18 undergoing CAPD for at least 3 months and able to read and understand Chinese
Patients experiencing moderate to severe pruritis, defined as persistent, treatment-resistant pruritis considerably impairing sleep or daytime activity. Treatment resistance is defined as no or only partial resolvement of pruritis under current anti-pruritis treatment regimens such as anti-pruritis lotions and anti-histamines.
Patients in stable clinical condition in terms of peritoneal dialysis and general health
Patients able to understand and answer the SDS questionnaire
Patients able to express the sensation of itchiness in the terms of the VAS and the SDS score
Patients who are willing to give written informed consent and to participate in and comply with the study protocol
Patients with a known history of pruritis or dermatologic disease antedating renal failure.
Patients with skin disease other than the usual cutaneous findings of uraemia such as xerosis or ecchymosis.
Patients under current treatment with systemic steroids
Known history of allergy to Gabapentin
Those patients already put on anti-convulsants
Unable to give written informed consent for the study
Pregnancy or female patients of child-bearing age who are unwilling to use contraception